In a new low-cost process, Mexicans managed to obtain paclitaxel, a drug for the treatment of cancer that is not available in Mexico and also has a high price.
The Technological Institute of Veracruz (Itver) houses several students who created, under a low-cost process, to develop paclitaxel, a drug used for more than 45 years for the treatment of cancer, which is not manufactured in our country and that currently has a high price.
The team designed a process called Quimioteraxol, which through the cultivation of plant cells of Mexican yew (Taxus globosa), generates the active compound of paclitaxel, a drug used to treat patients with lung, breast and ovarian cancer.
The team consists of Daniel Zavala Ortiz, a doctoral student in food science; Mauro Martínez Moreno, from the career of biochemical engineering; Juan Díaz Rangel, of electrical engineering; Rodolfo Bazán de la Cruz and Yerarli Pérez Salazar, with a master’s degree in biochemical engineering, in addition to the project’s advisors, Dr. María Guadalupe Aguilar Uscanga and Dr. Javier Gómez Rodríguez.
According to the El Universal newspaper interview, the research project started in 2002, from a thesis work, conducted by the student of the career of biochemical engineering at the Technological Institute of Veracruz, Oscar Plata, who was advised by the Dr. Guadalupe Uscanga.
Source: el universal, mexico primero noticias
The Mazatlan Post
